杏仁病:诊断,治疗,免疫学特征和与肠道生态系统的相互作用方面的进展
Patricia Morán1, Angélica Serrano-Vázquez1, Liliana Rojas-Velázquez1
1Laboratorio de Inmunología, Unidad de Investigación en Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Ciudad de México 06726, Mexico.
International journal of molecular sciences
|July 29, 2023
概括
人类虫病研究的最新进展揭示了对Entamoeba病变发生,诊断和宿主-寄生虫相互作用的新见解. 分子技术现在允许精确的物种和基因型识别,以改善患者护理.
科学领域:
- 传染性疾病 传染性疾病
- 寄生虫学的寄生虫学
- 分子生物学分子生物学
- 人类微生物组 人类微生物组
背景情况:
- 由Entamoeba物种引起的人类蜂蜜病仍然是一个重大的全球健康问题.
- 了解寄生虫的病原和宿主相互作用对于有效的疾病管理至关重要.
- 关于Entamoeba的遗传多样性及其与疾病呈现的相关性,以前存在知识差距.
研究的目的:
- 审查人类菌病的最新发现,重点关注病变发生,诊断和治疗.
- 探索Entamoeba寄生虫与人类肠道微生物群之间的复杂关系.
- 突出分子生物学和遗传学的进步,以表征Entamoeba菌株及其毒性.
主要方法:
- 对Entamoeba病变发生,宿主寄生虫相互作用和免疫反应的当前文献的综述.
- 对Entamoeba trophozoites的培养技术进步的分析.
- 整合了分子生物学和对Entamoeba基因组和多样性的遗传研究的发现.
主要成果:
- 多种不同的Entamoeba分离物的成功培养已经阐明了致病机制和宿主-寄生虫动态.
- 基因组和遗传分析揭示了Entamoeba的显著多样性,将特定的基因型与菌病形式联系起来.
- 先进的培养和分子诊断工具的开发允许精确的物种和基因型识别.
- 对免疫反应和Entamoeba-微生物群相互作用的更好理解有助于制定新的诊断策略.
结论:
- 最近的研究已经显著提升了对人类菌病的理解,从寄生虫生物学到宿主反应.
- 培养和分子诊断现在对于准确诊断和侵袭性氨菌病的管理至关重要.
- 阐明Entamoeba-微生物群相互作用提供了生态背景和潜在的治疗点.
相关概念视频
Fungal Phylum Microsporidia
41
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
41
Diversity of Protists IV
38
Amoebozoa represent a diverse group of terrestrial and aquatic protists that utilize lobe-shaped pseudopodia for locomotion and feeding. This characteristic differentiates them from the Rhizaria, which possess threadlike pseudopodia. The primary classifications within Amoebozoa include gymnamoebas, entamoebas, and the plasmodial and cellular slime molds. Phylogenetic evidence indicates that Amoebozoa diverged from a lineage that ultimately gave rise to fungi and animals.Gymnamoebas and...
38
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
355
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
355
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
158
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
158
Drugs for Treatment of Diarrhea-Predominant IBS
214
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
214
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
192
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
192


